Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
Specialty Chemicals grew 38% YoY for FY23
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Getinge has a strong market share in India within several product segments
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
Themis will market this drug with the brand name REMITHEM.
This registration enables companies to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization
Subscribe To Our Newsletter & Stay Updated
